ClinicalTrials.Veeva

Menu

Shock Wave Therapy for Sural Myofascial Pain Associated to Chronic Heel Pain

F

Foundation IRCCS San Matteo Hospital

Status

Completed

Conditions

Tendinopathy

Treatments

Other: Shock wave therapy on plantar fascia extended to the gastrocnemius-soleus trigger points
Other: Shock wave therapy on plantar fascia only

Study type

Interventional

Funder types

Other

Identifiers

NCT04385329
20160017179

Details and patient eligibility

About

The aim of this randomized controlled study in to investigate if a shock wave treatment extended to the gastrocnemius-soleus trigger points (TrP) is more effective than a standard treatment exclusively targeted at the plantar fascia in a population affected by unilateral plantar fasciitis with concomitant sural myofascial pain syndrome.

Enrollment

55 patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult age (18 to 75 years) and written informed consent;
  • Unilateral heel pain of four weeks or longer duration;
  • Pain to digital pressure in the insertional area of the plantar fascia at the calcaneum;
  • Sonographic examination showing a plantar fascia thickness greater than 3.8mm (see procedures for details);
  • Concomitant presence of a sural myofascial pain syndrome (SMPS), diagnosed on the basis of the finding, at the physical examination, of trigger points of the gastrocnemius-soleus muscle complex, according to Travel and Simons' original description.

Exclusion criteria

  • No corticosteroid injections or other physical therapies since the onset of the current pain episode (except pharmacological pain treatments and foot orthoses);
  • No general contraindication to shock wave therapy (pregnancy, bleeding disorders or anticoagulant drug usage, cancer in the focal area);
  • No clinical signs of lumbar radiculopathy at physical examination;
  • No ankle osteoarthritis, diagnosed on the basis of clinical and radiographic findings;
  • No previous fractures or surgery in the affected ankle and foot;
  • No rheumatologic diseases, no plantar fibromatosis

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

55 participants in 2 patient groups

Experimental group:shock waves extended to gastrocnemius TrP
Experimental group
Description:
Focused shock wave therapy was extended from the plantar fascia to the gastrocnemius-soleus trigger points.
Treatment:
Other: Shock wave therapy on plantar fascia extended to the gastrocnemius-soleus trigger points
Control group: shock waves not extended to gastrocnemius TrP
Active Comparator group
Description:
A standard focused shock wave therapy exclusively targeted at the plantar fascia
Treatment:
Other: Shock wave therapy on plantar fascia only

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems